Yoon Hyukjin, Kim Sung Hoon, O Joo Hyun, Seo Ye Young, Lee Yeongjoo, Kim Hyoungwoo, Ryu Jiyoung
Department of Radiology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, 137-701 Korea.
Department of Nuclear Medicine, College of Medicine, The Inje University Sanggye Paik Hospital, Seoul, Korea.
Nucl Med Mol Imaging. 2015 Dec;49(4):276-83. doi: 10.1007/s13139-015-0361-1. Epub 2015 Sep 1.
The aim of this study was to evaluate the value of thyroglobulin (Tg) kinetics during preparation of radioiodine ablation for prediction of initial radioiodine ablation failure in thyroid cancer patients.
Thyroid cancer patients after total thyroidectomy who underwent radioiodine ablation with 3-4 weeks of hormone withdrawal between May 2011 and January 2012 were included. Consecutive serum Tg levels 5-10 days before ablation (Tg1) and on the day of ablation (Tg2) were obtained. The difference between Tg1 and Tg2 (ΔTg), daily change rate of Tg (ΔTg/day) and Tg doubling time (Tg-DT) were calculated. Success of initial ablation was determined by the results of the follow-up ultrasonography, diagnostic radioiodine scan and stimulated Tg level after 6 to 20 months.
A total of 143 patients were included. Failed ablation was reported in 52 patients. Tg2 higher than 5.6 ng/ml and Tg-DT shorter than 4.2 days were significantly related to a high risk of ablation failure. ΔTg and ΔTg/day did not show significant correlation with ablation failure.
Thyroglobulin kinetics on consecutive blood sampling during hormone withdrawal may be helpful in predicting patients with higher risk of treatment failure of initial radioiodine ablation therapy in thyroid cancer patients.
本研究旨在评估甲状腺球蛋白(Tg)动力学在放射性碘消融准备过程中对预测甲状腺癌患者首次放射性碘消融失败的价值。
纳入2011年5月至2012年1月期间接受全甲状腺切除术后进行放射性碘消融且激素停用3 - 4周的甲状腺癌患者。获取消融前5 - 10天(Tg1)和消融当天(Tg2)的连续血清Tg水平。计算Tg1与Tg2的差值(ΔTg)、Tg的每日变化率(ΔTg/天)和Tg倍增时间(Tg-DT)。首次消融的成功与否通过6至20个月后的随访超声检查、诊断性放射性碘扫描和刺激后的Tg水平结果来确定。
共纳入143例患者。52例患者报告消融失败。Tg2高于5.6 ng/ml和Tg-DT短于4.2天与消融失败的高风险显著相关。ΔTg和ΔTg/天与消融失败无显著相关性。
激素停用期间连续采血的甲状腺球蛋白动力学可能有助于预测甲状腺癌患者首次放射性碘消融治疗失败风险较高的患者。